Profile | GDS4284 / 205544_s_at |
Title | Chronic lymphocytic leukemia response to antisense Bcl-2 inhibitor SPC2996: peripheral blood |
Organism | Homo sapiens |
Sample | Title | Value | Rank |
---|---|---|---|
GSM687644 | Patient 401 control | 2606.97 | 87 |
GSM687648 | Patient 402 control | 1785.23 | 82 |
GSM687653 | Patient 403 control | 1232.91 | 77 |
GSM687658 | Patient 404 control | 1120.65 | 76 |
GSM687663 | Patient 411 control | 1519.02 | 80 |
GSM687668 | Patient 422 control | 2022.91 | 84 |
GSM687673 | Patient 424 control | 2147.07 | 85 |
GSM687678 | Patient 425 control | 1286.5 | 77 |
GSM687683 | Patient 427 control | 3698.6 | 91 |
GSM687688 | Patient 428 control | 1042.66 | 75 |
GSM687695 | Patient 441 control | 1004.59 | 75 |
GSM687699 | Patient 443 control | 2268.65 | 86 |
GSM687704 | Patient 444 control | 1546.78 | 80 |
GSM687707 | Patient 448 control | 761.588 | 70 |
GSM687712 | Patient 449 control | 2782.94 | 88 |
GSM687719 | Patient 450 control | 1389.11 | 79 |
GSM687724 | Patient 451 control | 937.667 | 74 |
GSM687728 | Patient 452 control | 638.561 | 68 |
GSM687646 | Patient 401 treated 24h | 1714.66 | 81 |
GSM687649 | Patient 402 treated 24h | 1387.27 | 79 |
GSM687665 | Patient 411 treated 24h | 1767.87 | 82 |
GSM687651 | Patient 402 treated 4 weeks | 1575.59 | 80 |
GSM687667 | Patient 411 treated 4 weeks | 1561.9 | 80 |
GSM687670 | Patient 422 treated 24h | 2104.36 | 84 |
GSM687671 | Patient 422 treated 4 weeks | 2228.61 | 85 |
GSM687654 | Patient 403 treated 24h | 1451.08 | 80 |
GSM687675 | Patient 424 treated 24h | 2169.16 | 85 |
GSM687685 | Patient 427 treated 24h | 3526.9 | 90 |
GSM687656 | Patient 403 treated 4 weeks | 1993.9 | 84 |
GSM687677 | Patient 424 treated 4 weeks | 1717.75 | 82 |
GSM687687 | Patient 427 treated 4 weeks | 4674.06 | 93 |
GSM687692 | Patient 428 treated 4h | 1078.16 | 75 |
GSM687716 | Patient 449 treated 4h | 2601.46 | 87 |
GSM687722 | Patient 450 treated 4h | 1470.54 | 80 |
GSM687680 | Patient 425 treated 24h | 1226.87 | 77 |
GSM687690 | Patient 428 treated 24h | 1078.35 | 76 |
GSM687700 | Patient 443 treated 24h | 2237.58 | 86 |
GSM687705 | Patient 444 treated 24h | 2133.61 | 85 |
GSM687714 | Patient 449 treated 24h | 2444.82 | 86 |
GSM687721 | Patient 450 treated 24h | 1731.64 | 82 |
GSM687682 | Patient 425 treated 4 weeks | 1490.02 | 80 |
GSM687694 | Patient 428 treated 4 weeks | 960.128 | 73 |
GSM687702 | Patient 443 treated 4 weeks | 2224.09 | 85 |
GSM687718 | Patient 449 treated 4 weeks | 2330.39 | 86 |
GSM687723 | Patient 450 treated 4 weeks | 1867.72 | 83 |
GSM687661 | Patient 404 treated 4h | 1519.77 | 80 |
GSM687710 | Patient 448 treated 4h | 654.621 | 68 |
GSM687726 | Patient 451 treated 4h | 880.943 | 72 |
GSM687730 | Patient 452 treated 4h | 1058.99 | 75 |
GSM687660 | Patient 404 treated 24h | 1495 | 82 |
GSM687697 | Patient 441 treated 24h | 1115.22 | 76 |
GSM687709 | Patient 448 treated 24h | 717.669 | 69 |
GSM687725 | Patient 451 treated 24h | 1541.21 | 81 |
GSM687729 | Patient 452 treated 24h | 1056.53 | 77 |
GSM687727 | Patient 451 treated 4 weeks | 989.355 | 74 |
GSM687731 | Patient 452 treated 4 weeks | 684.463 | 68 |